1C1 Lymphoma (Case 1) CD20 | Lymphoma, primary | NEOPLASMS (HEMATOLYMPHOID)

Washington University Experience | NEOPLASMS (HEMATOLYMPHOID) | Lymphoma, primary | 1C1 Lymphoma (Case 1) CD20

Immunohistochemical stains reveal strong reactivity of the tumor cells to CD20, a B-cell marker.